Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil Once-a-Day for BPH in Japanese Men
NCT00783094Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tadalafil in benign prostatic hyperplasia (BPH) (3 arms), sponsored by Eli Lilly and Company. Primary endpoint: Change From Baseline in International Prostate Symptom Score (IPSS) Total Score at 12 weeks. Started Nov 2008; status: completed.
02
Drugs
tadalafil
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00783094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00783094.